Riskpilot← Back to searchSign inGet full accessDr Beijer läkarpraktik AB
ABActiveOrg 5591535637Musslestigen 3Medical specialists activities · NACE 8622Est. 20180 employees
Revenue 2024
SEK 1,9M
+43% vs 2023
EBITDA margin
74.9%
+62% vs 2023
Equity ratio
93.9%
Financial strength
Net profit 2024
SEK 1,1M
+64% vs 2023
| Revenue | SEK 1,9M | +43% |
| EBITDA | SEK 1,4M | +62% |
| Net profit | SEK 1,1M | +64% |
| Total assets | SEK 1,9M | +25% |
| Equity | SEK 1,8M | +31% |
| Employees | 0 | — |
Legal name
Dr Beijer läkarpraktik AB
Org number
5591535637
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 mars 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva verksamhet inom följande områden: psykiatri, beroende, medicin, neurologi, telemedicin samt forskning, utredningar och föreläsningar inom dessa områden. Dessutom skall bolaget bedriva ekonomiska konsultationer samt konsultationer inom hälsoekonomi och life science. Vidare skall bolaget bedriva litteraturutgivning och kursverksamhet.
Address
Musslestigen 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 952 | 1 113 | 1 235 | 1 337 | 1 908 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 491 | 773 | 942 | 882 | 1 430 |
| Depreciation & amort. | −0 | −7 | −7 | −7 | −7 |
| EBIT | 491 | 766 | 935 | 875 | 1 423 |
| Net financials | −1 | — | −2 | 2 | 10 |
| Profit before tax | 490 | 765 | 933 | 877 | 1 433 |
| Tax | −119 | −143 | −193 | −189 | −306 |
| Net profit | 371 | 622 | 740 | 688 | 1 127 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 771 | 1 186 | 1 460 | 1 562 | 1 948 |
| Equity | 426 | 818 | 1 183 | 1 401 | 1 829 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 345 | 368 | 277 | 161 | 120 |
| Total debt | 345 | 368 | 277 | 161 | 120 |
EBITDA margin
74.9%
This company
15.8%
Market median
+374% vs market
20202024
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
61.6%
This company
18.4%
Market median
+235% vs market
20202024
Net profit margin
59.1%
This company
8.1%
Market median
+630% vs market
20202024
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2022 | |
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Beijer läkarpraktik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Anne Ålholm Beijer | Board of Directors | 0 companies |
| Gunbritt Marie Beijer | Deputy Board Member | 0 companies |
| Karl Emil Beijer | Chairman | 0 companies |